Abstract
Gene drives are selfish genetic elements which promise to be powerful tools in the fight against
vector-borne diseases such as malaria. We previously proposed population replacement gene drives
designed to better withstand the evolution of resistance by homing through haplolethal loci. Because
most mutations in the wild-type allele that would otherwise confer resistance are lethal, only successful
drive homing permits the cell to survive. Here we outline the development and characterization of two
ΦC31-Recombination mediated cassette exchange (RMCE) gene drive docking lines with these features
in Anopheles gambiae, a first step towards construction of robust gene drives in this important malaria
vector. We outline adaption of the technique HACK (Homology Assisted CRISPR knockin) to knock-in
two docking site sequences into a paired haplolethal-haplosufficient (Ribosome-Proteasome) locus, and
confirm that these docking lines permit insertion of drive-relevant transgenes. We report the first
anopheline proteasome knockouts, and identify ribosome mutants that reveal a major hurdle that such
designs must overcome to develop robust drives in the future. Although we do not achieve drive, this
work provides a new tool for constructing future evolution-robust drive systems and reveals critical
challenges that must be overcome for future development of gene drives designed to target haplolethal
loci in anophelines and, potentially, other metazoans.
1
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Background
Gene drive technology could revolutionize the control of vector-borne diseases [1,2]. Designed to either
suppress wild populations or replace them with disease-refractory ones, gene drives have been proposed
as a viable tool to control diseases such as malaria [3]. Homing gene drives (HGD) are artificial selfish
genetic elements capable of copying themselves from one homolog to the other by homology directed
repair (HDR). This copying is catalyzed by targeted CRISPR cleavage of the non-drive chromosome and
repair of the break with the drive transgenic cassette. If this occurs in the germline, this results in
Super-Mendelian inheritance of the gene drive cassette, spreading desirable genetic cargoes or traits
throughout the population. HGDs can therefore be used to spread sterilizing or antipathogenic traits,
resulting in population suppression or population replacement respectively, to achieve different vector
control outcomes.
Inherent to any HGD design is the generation of resistance alleles at the target locus. Generated as a
byproduct of end-joining repair following CRISPR cleavage, they are an inevitable hindrance of many
drive designs [4–7]. Resistant-conferring polymorphisms prevent subsequent guide RNA (gRNA) binding
and cleavage, preclude future drive, and often compete the drive to extinction [6–9]. Though some drives
target haplosufficient genes to provide some selection against resistance allele formation [10,11], all gene
drives developed in anophelines to date have induced some level of resistance [3–21]. Resistance alleles
can be categorized into two types; r1 resistance alleles are those which preserve the function of the target
gene, while r2 alleles are those which disrupt gene function. Both must be prevented to guarantee drive
spread [22]. Our previously proposed drive designs, termed Evolutionarily Stable Homing Gene Drives
(ESHGDs), use multiple gRNAs to home into a haplolethal target. In doing so they can theoretically
prevent both types of resistance [1,23,24], as r1 alleles are deleted during homing and r2 alleles are lethal.
This design causes only correct drive homing to be survivable for the cell. ESHGDs are not to be
confused with other drive designs targeting a haplolethal locus, whose long-term success is unlikely. In
these designs there are additional homologous sequences within the recoded region, making HDR with
these sequences likely, causing transgene shuffling[25] and probable failure of this drive design.
Recombinase Mediated Cassette Exchange (RMCE) is a technology for docking desired cargoes onto
ΦC31 attB or attP sequences, enabling precise insertion of genetic cargoes onto target sequences. Here we
report on the generation of two gene drive RMCE docking lines with the recoding and genetic
engineering necessary to enable the creation of ESHGDs. We set out to generate docking lines within the
dual-gene haplolethal-haplosufficient gene locus, Ribosome Protein L11 and Proteasome Regulatory
Particle Subunit 1 (RpL11-Rpt1). In doing so we replace the 3’-terminal coding and UTR sequences with
2
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
recoding and replacement UTRs, while providing ΦC31 RMCE docking sequences for subsequent
transgenesis of drives. We demonstrate that one of these docking lines is an expected proteasome
knockout, while the other is an unexpected Ribosome Minute mutant. While we are unable to demonstrate
homing, we demonstrate that these docking lines can support transgenesis of a drive-like transgene, and
may be able to support a drive following future fine-tuning of Cas9 expression. In all, this work presents
an important advancement in the development of gene drives that are less susceptible to resistance.
Results
Design of two gene drive docking sites, dRP and dRPi
Our ESHGD designs target haplolethal genes to make any non-drive outcome lethal for the cell. In these
designs the 3’-terminal coding sequence and 3’UTR are deleted from a haplolethal gene and are replaced
with recoded coding sequence and a 3’UTR from a similarly regulated paralog. This design is meant to
reconstitute gene function while creating a region not shared with the wild type homolog, which can be
uniquely targeted with multiple gRNAs, over which HDR can not occur (Figure 1A, B). In a subsequent
transgenesis step, CRISPR-encoding drive sequences are inserted immediately adjacent to the recoded
haplolethal gene, without disrupting it. By targeting the wild type haplolethal coding sequence, such
drives are intolerant of r2 mutations due to the essentiality of the haplolethal gene product [4], and
simultaneously delete any r1 alleles which do arise during homing due to the HDR-inhibition caused by
the recoding. This design theoretically circumvents the issue of resistance which has plagued most drives
to date [4,9,22,26–28], exhibiting a true delete-and-paste function [29] in which only successful drive
homing allows the cell to survive. This makes inheritance of the recoded gene ‘addictive’[30].
Optimal ESHGD designs span two adjacent haplolethal genes positioned in a 3’-to-3’ orientation to create
distinct recoded boundaries for homing on each side of the drive cassette. While Ribosomal subunit
proteins [31], due to the need for 10 million copies per cell [32], effectively guarantee homolog
haplolethality, a 3'-to-3' Ribosome-Ribosome gene pair does not exist in the A. gambiae genome. We
therefore selected the Ribosome-Proteasome gene pair RpL11-Rpt1 as the target for our evolutionarily
stable gene drive docking lines (Figure 1A). RpL11(AGAP011173) is a 60S well-characterized ribosomal
subunit [31], whose stop codon is only 1128 bp from the stop codon of Rpt1, a likely haplosufficient
essential ortholog 26S proteasome subunit T1 [33], making these genes a good candidate pair. Due to the
complexity of the genome engineering required, we originally set out to design the gene drive in two
steps. In the first step the gene drive docking lines would carry the necessary recoding, engineering, and
3
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
RMCE-compatible ΦC31 docking sequences (reported herein) [3], prior to constructing a full gene drive
in the locus in a later second step.
In selecting the RpL11-Rpt1 gene pair, we developed two docking site designs. The first design sought to
maintain endogenous function of both RpL11 and Rpt1 to facilitate ‘classic’ population replacement gene
drives characterized by homozygous viability. For this we recoded 183 bp and 253 bp of RpL11 and Rpt1
respectively [34], removed intron 3 from RpL11, and provided surrogate 3’UTRs from RpL32 and Rpt3
respectively (Table S1). Further included are two attP Φ C31 sites for RMCE, and a 3xP3-CFP marker for
selection. We named this docking line dRP (docking site in Ribosome and Proteasome) (Figure 1B).
However, because the Rpt1 homolog is likely haplosufficient, heterozygous r2 alleles could persist in
driving populations with this docking site design. We therefore designed a second docking site with Rpt1
knocked-out in the drive-containing chromosome to render the remaining wild type Rpt1 allele
hemizygous, and thereby haplolethal, by omitting the 3’UTR from Rpt3. This line is characterized by
3xP3-EYFP with all remaining recoding identical to dRP. We named this design dRPi (docking site in
Ribosome with Proteasome inhibited) (Figure 1B).
These two docking site designs permit two broadly different gene drive types. Gene drives in dRP
theoretically should permit population replacement and should be capable of driving to allelic fixation
(Figure S1A). However these drives would experience less stringent selective pressures to guarantee
homing due to tolerance of r2 alleles in Rpt1, which could inhibit drive spread. Drives inserted into dRPi
would however prevent r2 alleles in Rpt1, but would be homozygous lethal due to Proteasome knockout.
We argue this does not preclude powerful replacement drive designs. In a drive design we term Recessive
Lethal Replacement (RLR), a homozygous lethal gene drive could reach population fixation as
heterozygotes when spread by a single sex (Figure S1B). This drive would have the added benefit of
simultaneous 50% population suppression in conjunction with population replacement in heterozygous
form, and could thereby still meet anti-pathogen goals with inclusion of any dominant-acting
antipathogen cargo [8]. Importantly both docking sites could also equally permit suppression or
replacement drive designs, depending on the drive cargo, part of the elegance of these designs.
Constructing dRP and dRPi through HACK
Direct embryonic microinjections to integrate dRP and dRPi by HDR appeared to be lethal, as we did not
obtain any transformants despite repeated attempts (n=2732 embryos injected, n=245 embryos survived,
8.9% survival, compared to normal ~25% survival). We therefore set out to harness the endogenous
Interlocus Gene Conversion (IGC) phenomenon to knock-in the dRP and dRPi templates into RpL11-Rpt1
4
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
in the germline of transgenic adults. IGC is a naturally occurring gene knockin method which templates
repair not from an exogenously provided template but from distal loci. For this we developed two donor
transgenes, dRPpBdonr and dRPipBdonr that contain the dRP and dRPi cassettes respectively, homology arms
flanking RpL11-Rpt1, 8 gRNAs targeting the wild type 3’ termini of RpL11-Rpt1 coding sequences
(gRNAL-S), and a second fluorescent selectable marker Act5C-DsRed outside of the Homology arms
(Figure 1C). These donors were integrated into the genome randomly by piggyBac transgenesis and were
crossed to Cas9 (VZC) [35] to generate hybrid male mosquitoes capable of IGC in the germline, (+/VZC ;
+/dRPpBdonr) and (+/VZC ; +/dRPi pBdonr) genotype. The offspring larvae from these males were visibly
scored for the expression of their respective 3xP3-FP cassettes (CFP and EYFP in dRP and dRPi
respectively) unlinked from Act5c-DsRed, indicating integration of dRP or dRPi into RpL11-Rpt1 and
dislinkage from dRPpBdonr and dRPipBdonr(dRPi shown, Figure 1D). Integration was confirmed by PCR and
sequencing (Figure 1E, 2B). Following these experiments, we adopted the acronym Homology Assisted
Crispr Knockin (HACK) to describe the phenomenon of IGC-mediated gene knockin [36,37].
We performed a brief analysis of the conditions required for HACK to aid the construction of future
similar drive designs. Five dRP pBdonr families with different insertion sites were assayed for their ability to
template HACK of dRP into the endogenous RpL11-Rpt1 locus (Figure 1F ) (dRP pBdonr
[1], dRP pBdonr
[2] ,
dRPpBdonr
[3], dRP pBdonr
[4], dRP pBdonr
[5]). Two of the families, those on the same chromosome arm as the
RpL11-Rpt1 target (Families dRP pBdonr
[4] , and dRP pBdonr
[5]), yielded HACK-positive larvae when screened
for by 3xP3-CFP-positive and Act5c-DsRed-negative fluorescence [38]. However the frequency of
HACK-positive larvae was significantly higher when assayed by PCR among those who co-inherited
dRPpBdonr, suggesting linked activity (Figure 1G ). In these larvae, HACK of dRP into RpL11-Rpt1 and its
associated 3xp3-CFP marker was ‘masked’ due to coinheritance with the dRP pBdonr transgene containing
both 3xP3-CFP and Actin5c-DsRed cassettes. This suggests HACK occurred frequently in these families,
but dislinkage of fluorophores through recombination or homing occurred rarely, suggesting post-Meiosis
I activity. HACK was not observed visually via fluorescence from dRP pBdonr donors localized to a different
chromosome than the RpL11-Rpt1 target, however PCR was not performed to identify if integration was
occurring in the absence of fluorophore dislinkage. However, the dislinkage of dRP pBdonr from newly
integrated dRP in these lines should have allowed for identification of integrants readily via fluorescence
if it was occuring. Characterization of HACK in the dRPipBdonr families was not undertaken.
In sum, HACK-based integration of both separate dRP and dRPi templates occurred from different
dRPpBdonr and dRPi pBdonr donor loci. Taken together, these findings suggest that HACK is a reproducibly
robust technology for engineering genetically intractable haplolethal loci, and most likely occurs when
donor and target are linked. Furthermore these findings also demonstrate a critically important principle
5
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
that homology-based repair can be tolerated in the RpL11-Rpt1 locus when stimulated by cleavage via
gRNAL-S.
Characterization of dRPi and insertion of drive-like transgenes
We next set out to characterize dRPi, but chose to do so in conjunction with inserted genetic cargoes, as
the binary fluorophores more easily permit identification of homozygotes at the dRPi site. Into dRPi
(3xP3-EYFP fluorophore) we transgenically inserted via RMCE a drive-like transgene termed gDLT
(gRNA-expressing Drive-Like Transgene; 3xP3-DsRed fluorophore) (Figure 2A, Table S2),
characterized by a non-expressing truncated Nanos promoter (Figure 2C) [39] upstream of Cas9, and
containing expression cassettes for gRNA L-S (Figure 2A). Integration of gDLT in dRPi was confirmed by
PCR (Figure 2B). Crossing gDLT to dRPi enabled identification of transhomozygotes by fluorescence
(gDLT/dRPi) which died prior to the first larval molt (n=28/28 died). Further analysis revealed that they
experienced significant accumulation of polyubiquitin aggregates before death (Figure 2D), possibly due
to knockout of Rpt1 caused by the lack of replacement 3’UTR (Figure 1A). Importantly, gDLT represents
a transgene with expression cassettes, size, and cargoes reminiscent of a functioning gene drive -
including gRNAs - as it spans 1.7kB removed and 12.5kB inserted by RMCE into the docking site (Table
S2). This suggests that the dRP and dPRPi docking sites may be able to tolerate integration of gene
drives, and that the intergenic distance between RpL11 and Rpt1 is not of critical importance at the scales
required for drive integration.
Failure to observe homing due to lethality and sterility
We next generated multiple gene drive constructs for integration into dRPi. All constructs expressed
gRNAL-S, and differed only in the sequences regulating Cas9, including Vasa[41], B2-tubulin[42] and two
iterations of the ZPG[3] promoter. However, following injections of 7,014 dRPi and 1,012 dRP embryos,
only 7 transgenics were recovered which all died as first instar larvae, suggesting insertion of gene drive
transgenes into these sites may be lethal. These transgenes presumably expressed Cas9 as the promoters
were identical to those previously published, while gDLT does not express Cas9 (Figure 2C). This
suggests that the docking site may be sensitive to toxic Cas9 overexpression from inserted transgenes,
possibly due to adjacent ribosomal enhancers [43].
We then assayed the drive potential of gDLT by providing Cas9 in trans in a split-drive-like design,
crossing to the VZC Vasa2-Cas9 line [35,44]. In a cross of transheterozygous males (+/gDLT; +/VZC)
mated to wild type females, the resulting broods were completely sterile (0% fertility, n = 0/482 eggs laid,
6
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Binomial two-tailed p<0.0001), compared to control crosses of (+/VZC) sibling males which displayed
normal fertility (89.9% fertility, n = 1321/1469 eggs laid, Binomial two-tailed p<0.0001). Females with
the drive genotype (+/gDLT; +/VZC) experienced significant mortality 24H post-blood feeding (n =
10/15), impaired oviposition (n = 4/15), or oviposition of infertile clutches (n = 1/15)(Figure 2E,
p<0.0001 One Way ANOV A). Taken together, these findings demonstrate significant perturbation of the
reproductive biology of driving individuals consistent with significant mutagenesis of RpL11-Rpt1, and
suggesting that CRISPR expression must be finely tuned in these designs - whether transgenically from
within the docking sites or when provided in trans in a Split-drive-like formation - to permit fertility and
observable drive.
dRP homozygotes are Ribosome Minute mutants
During the course of experiments we discovered that dRP is homozygous inviable - a phenotype only
expected of dRPi due to proteasome knockout. dRP-positive larvae reached pupation significantly more
slowly (Figure 3A), most (dRP/dRP) individuals failed to survive eclosion (Figure 3B), (dRP/dRP) were
significantly smaller as adults (Figure 3C), and females failed to develop normal ovaries following blood
feeding - even in the absence of CRISPR (Figure 3D)[45,46]. These findings point towards (dRP/dRP)
individuals being Ribosome Minute mutants with growth-defect phenotypes indicative of ribosome
scarcity [47]. In concordance with this, RpL11 mRNA levels are significantly reduced in (dRP/dRP)
(Figure 3E). We postulate this may be a result of recoding, differential regulation caused by the Rpt3
3’UTR, or deletion of a necessary intergenic enhancer during docking line construction. Importantly, there
were no significant differences in expression of Rpt1 in this line (Figure 3F ), and no observable
accumulation of Poly-ubiquitin aggregates in these individuals (Figure 3G ), indicating that the recoded
Proteasome is functioning correctly as designed and the defect likely lies with RpL11.
Discussion
Developing gene drives that are resistance-proof may be necessary to achieve malaria control on a
continental-wide scale [3]. Here we take the first steps towards development of potentially more
resistance-proof HGDs in Anopheles gambiae by developing gene drive docking sites in a haplolethal
Ribosome-Proteasome locus. We demonstrate reproducible knockin of the docking sites dRP and dRPi
into the RpL11-Rpt1 locus by HACK, and demonstrate survivability despite significant 3’ terminal
recoding. In recoding, we undertake some of the first targeted whole-body engineering of endogenous
ribosome genes in eukaryotes, laying the groundwork for not only gene drives, but study into the
ribosome’s role in everything from ecdysone signaling, to oncogenesis to prion folding [48–50]. We
7
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
discover that dRP displays a Ribosome Minute phenotype - (Figure 3), and characterize the proteasome
knockout phenotype characteristic of dRPi (Figure 2D), the first such phenotypes in Anophelines to our
knowledge (Figure 2D). We demonstrate that these docking sites are capable of RMCE insertion of a
drive-like transgene, gDLT (Figure 2A-D), however they cannot currently harbor fully functioning gene
drives likely due to a combination of Cas9 toxicity and Ribosome-depletion phenotypes (Figure 3).
Though beyond the scope of this work, different strategies could be used to demonstrate gene drive of
dRP or dRPi. Fine-tuning Cas9 expression using insulators, codon-deoptimization, induction systems, or
nickases could be employed, in addition to novel promoter expression systems [5]. Assaying for homing
as a split-drive design could enable characterization of necessary components in isolation, and providing
an additional transgenic copy of recoded RpL11 could alleviate Minute phenotypes. In designing these
systems such that only successful homing permits the cell to survive, it is clear that more finely-tuned
Cas9 is required to enable drive while not causing lethality or toxicity of surrounding germline tissue.
Beyond traditional homing gene drives, these docking sites could also enable construction of CLvR or
HomR systems with one of the recoded genes providing the necessary gene rescue gene product for
function [51,52].
HACK was used to generate these lines, and may provide a valuable tool for engineering genetically
intractable loci for future drive systems. Two different donor sites were used successfully to generate dRP
and separately dRPi was generated using a unique donor line, suggesting HACK is recapitulatable so long
as the donor is on the same chromosome as the recipient locus. This technology promises to be useful for
creating drives in intractable loci in the future.
In all, these lines represent a significant advancement in the development of haplolethal-targeting gene
drive designs, and present important avenues for future study. They represent the most advanced
haplolethal-targeting drive designs in Anophelines to date, and with future optimization may form the
basis of powerful gene drive designs. Despite the absence of drive, our work still presents a major
advancement in knowledge in the phenotypes and construction of haplolethal-targeting gene drive
designs, providing important insights for the field of vector control and similar drive designs being
developed in other metazoans.
8
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Methods
gRNA design
8 gRNAs were designed and selected based on their in silico cleavage prediction
(https://zlab.bio/guide-design-resources). All gRNAs were designed in 4 pairs, two pairs each targeting
the 3’ terminus of each gene, and were designed in such a way to enable cleavage with a Cas9 nickase to
generate overhangs to further bias for HDR. gRNAs L and M were synthesized as a tethered pair with
alternative scaffold sequences from S. pyogenes and S. mutans. Their sequence can be found in Table S3.
gRNAs N and O were synthesized as a tethered pair with alternative scaffold sequences from S. Pyogenes
and S. agalactiae. Their sequence can be found in Table S3. gRNAs R and S were synthesized as a
tethered pair with alternative scaffold sequences from S. Pyogenes and S. agalactiae. Their sequence can
be found in Table S3. gRNAs P and Q were synthesized as a tethered pair with alternative scaffold
sequences from S. mutans and S. pyogenes. Their sequence can be found in Table S3.
Recoding
Recoding was undertaken manually using the codon optimization table found in V olohonski et al [34]. All
codons were recoded to the next-most common codon, giving preference to the most common codons.
Codons with <20% frequency were omitted. Surrogate 3’ UTRs from RpL32 and Rpt3 were manually
selected to replace the endogenous RpL11 and Rpt1 3’UTRs. They were chosen based on subunit
stoichiometry in respective protein complexes and a general understanding of protein function. Full
sequences can be found in Table S1.
Cloning and transgenesis
Cloning of dRP pBdonr, dRPi pBdonr, and gDLT was undertaken using standard molecular biology protocols
including Golden Gate and Gibson. These plasmids were established transgenically following standard
molecular biology protocols and were used to generate dRP and dRPi lines respectively (see “Interlocus
gene conversion crosses to establish dRP and dRPi” below). Due to the Pandemic, these plasmids are
no longer available. Therefore the full plasmid sequence with feature annotation is available in
Supplementary Table 1 and 2. The difference between dRP pBdonr and dRPi pBdonris omission of the Rpt3
3’UTR. Additional gRNA target sequences were included in the plasmid to amplify cleavage by a second
generation of gene drives at this site not otherwise discussed. gRNA cleavage sites for a second
generation gene drive are noted as gRNAL’,M’,N’,O’,P’,Q’,R’, S’ in Supplementary Table 1. Second
generation gene drives are however not further discussed in this work. Vasa-Cas9, VZC, transgene was
9
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
reported previously [35]. The transgene gDLT sequence is provided and annotated in Supplementary
Table 2.
Inverse PCR on dRPpBdonr to determine integration loci
Inverse PCR was essentially as described in [53]. In essence, 1-3uL of genomic DNA was digested with
TaqI enzyme for 4h. This was then circularized with ligase in a 100uL reaction. The sample was
concentrated by precipitation via Sodium Acetate then was resuspended in 10uL water. 1uL of this
preparation was used as a template for PCR. PCR was carried out with the primers 1114H.S3 and
1114H.S4, (5’ CTGTGCATTTAGGACATCTCAGTC 3’) and (5’ GACGGATTCGCGCTATTTAGAAAG
3’) respectively, the latter of which amplifies outwards beyond the piggyBac terminal repeat and into
adjacent genomic sequences. PCR amplicons were gel extracted, cloned into pJET (Thermo Scientific,
Cat. No. / ID: K1231), and individually sequenced.
Interlocus gene conversion crosses to establish dRP and dRPi
F0 VZC males and dRP pBdonr, dRPi pBdonr females were crossed together en masse (approximately 50-100
individuals each genotype). They produced F1 hybrid {+/VZC; +/dRP pBdonr} or {+/VZC ; +/dRPi pBdonr}
offspring. Among these F1 offspring, males were outcrossed to WT in mass (approximately 50-100
individuals each genotype), and the F2 offspring were screened for integration of dRP or dRPi by
fluorescence. Fluorescence was visible as 3xP3-CFP or 3xP3-EYFP in the absence of Actin5c-DsRed
respectively for dRP and dRPi.
Western Blots
Western blots were carried out essentially as described in [54]. For Cas9 Westerns 7 5-10 day old male
lower abdomen or female ovaries were prepared, and for Poly-ubiquitin Westerns, 30 1 day old larvae
were genotyped by fluorescence and and prepared in Np-40 cell lysis buffer system (ThermoFisher
Scientific) supplemented with 1mM PMSF in DMSO and 40µ Protease Inhibitor. Western blots to detect
Cas9 were carried out with α-Cas9 [Cell Signaling Technologies ®(Cas9 XP ®, Rabbit mAB # 19526,
1:1000 dilution)]. Westerns targeting poly-ubiquitin failed to identify an anopheline positive control,
therefore a murine tissue culture sample with known proteasome defects was used as a positive control
which does not stain for actin (1µg/µL C2C12 cell line treated with Bortezomib). Membranes were
treated with 6M GuHCl, 20mM Tris pH 7.5, 1mM PMSF and 5mM βME for 30 min at 4° to release
Poly-ubiquitinated tails from aggregates [55], before blocking and antibody incubation with 1:500
solution of the Fk2 Mono- and polyubiquitinated antibody (Enzo Life Sciences, BML-PW150-0025).
10
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Genotyping PCR
Genotyping PCRs were undertaken on single 4-8 day old adults following standard Molecular Biological
protocols. PCR for the presence of the WT RpL11-Rpt1 allele was undertaken with primers als561 and
als287, [5’ CGGGCATGTTTGCGATTC 3’] and [5’ CTGACCAAGGAGGACGCG 3’] respectively,
spanning the 3’ terminal coding region of wild type RpL11 and Rpt1 for an amplicon of 1577 bp. PCR for
the presence of the integrated docking site, dRP or dRPi, was amplified with primers als328 and als306,
[5’CACACCTTTACATATCGCTCGC 3’], [5’ GTACCTTCCAGGTCGTAGTCTTG 3’], spanning the
Rpt1 5’ UTR outside of the homology arms and the length of the Rpt1 coding sequence. The amplicon is
2,193 bp in dRP, and 1,995 bp in dRPi due to the presence or absence of the surrogate Rpt3 3’UTR
respectively. The dRP pBdonr was PCR amplified with primers als287 and als478, [5’
CTGACCAAGGAGGACGCG 3’] and [5’ GTGATGGTCACGGTGCTTTTAC 3’], respectively,
amplifying the gRNAs and Actin5c promoter, for a 916 bp fragment. Control S7 PCRs were amplified
with FC107 and FC108, [5’ GGCGATCATCATCTACGTGC 3’] and [5’
GTAGCTGCTGCAAACTTCGG 3’], targeting the wild type ribosomal S7 subunit. The gDLT primers als
291 [5’GCGGTCAACAAGGTGACAAGG 3’] and als342 [5’ CTGCGTCGCGACAACTTCTC 3’]
amplify from the wild type sequence of RpL11, over the recoding and ΦC31 recombination sequence, and
into the gRNA cassettes on gDLT, 1620 bp predicted size.
qRT-PCR
Samples for quantitative RT-PCR were two 3 day old adults, one male one female, diluted tenfold and
quantified in triplicate using standard curves. PCRs were run in Fast SYBR Green Master Mix
(Thermo-Fisher) on a Step One Plus thermocycler (Applied Biosystems).
qRT-PCR amplification of RpL11 was undertaken with als1024 and als1025, [5’
TAAGGTAGCCACAATGCCAGC 3’] and [ 5’GCGCATCACGTTCTTCGACT 3’] respectively,
targeting the first exon-exon junction and overlapping the start codon, an unmodified sequence shared by
both the recoded and wt alleles of RpL11. qRT-PCR amplification of Rpt1 was undertaken with als1018
and als1019, [5’ AGGTGAACGAACTGACGGG 3’] and [5’ CCTGAAGCGGCTGCTCATT 3’]
targeting exon 3 of Rpt1, a shared sequence in both recoded and wt Rpt1. Quantities were normalized
against the ribosomal protein RpL19 using previously described primers[56].
Assaying for inheritance bias
Females carrying either the +/gDLT, +/VZC, or +/gDLT;+/VZC phenotype were mated ad libitum to wild
type males for 3 days. They were then bloodfed and isolated into individual oviposition cups to lay their
11
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
eggs. The resulting larval broods were then scored for the number of fluorescent larvae over the total
number of larvae. They were then plotted as a percentage of transgenic offspring over total. Females
which died or laid wholly infertile broods are plotted in open dots at left.
Delayed pupation assay
Broods resulting from an intercross of +/dRP x +/dRP parents were raised with approximate larval density
of 200 larvae per tray. Within any given brood, the number of transgenic or wild type individuals pupating
each day was scored. Transgenic individuals included both +/dRP and dRP/dRP hetero- and
homozygotes. The data is plotted as an inverse survival curve with day 6 corresponding to the last date of
pupation and a percentage of 100%
Pupal mortality assay
dRP/dRP and WT sibling individuals were identified and separated as L4 larvae by fluorescence intensity.
They were allowed to pupate and were checked over the course of 2 consecutive days. The number of
successfully eclosed, dead, and drowned adults were counted.
Ovarian dissection
Female dRP/dRP and WT were genotyped as L4 larvae, then allowed to eclose into adults. At 3 days old
they were provided a blood meal to induce oogenesis. 48h later the reproductive tract was dissected and
imaged under a Leica Stereomicroscope.
Data availability
Complete sequence maps and plasmids are available in Table S1 and S2 . Transgenic lines dRP and dRPi
are upon request to O.S.A.
Acknowledgments
We thank Emily Lund, Reema Apte, James Pai, Sansa Chen, Martha Chow, Michelle Bui, Julika Job, and
Simon Joseph for helping with mosquito husbandry.
This research was funded by the Howard Hughes Medical Institute/Bill and Melinda Gates Foundation
Grant OPP1158190 to F.C; by the National Institutes of Health (NIH) (award number R01 AI104956 to
F.C.; and by an F31 AI120480-02 to A.S. F.C. is funded by the Howard Hughes Medical Institute (HHMI)
as an HHMI investigator. Defense Advanced Research Projects Agency under the Safe Gene program to
K.E. and G.C.; Burroughs Welcome Fund IRSA 1016432, and NIH R00-DK102669-04 to K.E. This
12
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
work was supported by funding from NIH awards (R01AI151004, RO1AI148300, RO1AI175152)
awarded to O.S.A. The findings and conclusions within this publication are those of the authors and do
not necessarily reflect positions or policies of the HHMI or the NIH. The funders had no role in the study
design, in data collection, analysis or interpretation, in the decision to publish, or the preparation of the
manuscriptFigures were created using www.BioRender.com.
Author Contributions
A.L.S conceptualized and designed experiments, performed molecular analysis and genetic experiments,
analyzes and compiled the data, wrote the manuscript draft and contributed to final manuscript editing;
E.A.M., S.S., and E.M. performed molecular analyses, and genetic experiments; O.S.A provided
mentorship, provided husbandry support, and edited the manuscript. G.M.C. provided significant
intellectual contributions and edited the manuscript. F.C provided mentorship, significant intellectual
contributions, and edited the manuscript. K.M.E designed experiments, provided significant intellectual
contributions, and edited the manuscript. All authors approve the final manuscript.
Ethical conduct of research
All animals were handled in accordance with the Guide for the Care and Use of Laboratory Animals as
recommended by the National Institutes of Health and approved by the UCSD Institutional Animal Care
and Use Committee (IACUC, Animal Use Protocol #S17187) and UCSD Biological Use Authorization
(BUA #R2401).
Disclosures
O.S.A is a founder of Agragene, Inc. and Synvect, Inc. with equity interest. The terms of this
arrangement have been reviewed and approved by the University of California, San Diego in
accordance with its conflict of interest policies. G.M.C. has the following patents related to this
work: WO2015006290A1 (“Multiplex RNA-guided genome engineering”) and
WO2016089866A1 (“RNA-guided systems for in vivo gene editing”). A complete list of
G.M.C’s conflict of interest can be found at arep.med.harvard.edu/gmc/tech.html. K.M.E. and
A.L.S have pending patents related to the described work: WO2015105928A1 (“RNA-guided
gene drives”) and K.M.E. has an additional patent WO2015006294A2 (“Orthogonal Cas9
proteins for RNA-guided gene regulation and editing”). All other authors declare no competing
interests
13
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
FIGURES
Figure 1. Design and HACK-based integration of dRPi and dRP into RpL11-Rpt1. [A] The endogenous wild type RpL11-Rpt1 target
locus on Chromosome 3L shown to scale. Location of 8 gRNA binding sites (red) targeting the C-terminal coding sequence of each
gene. [B] Design of dRPi and dRP docking sites, not to scale. Codon recoding (vertical grey bars) corresponds to the C-terminal 183
bp and 258 bp of RpL11 and Rpt1 respectively. RpL11 intron 3 was removed (vertical black bar), and replacement surrogate 3’UTR
from RpL32 provided (209 bp, purple). In dRP a replacement 3’UTR from Rpt3 is provided to Rpt1 to reconstitute gene function
(orange), in dRPi it is omitted to eliminate Rpt1 function. Also included are attP sequences for ΦC31 transgenesis of subsequent
drive designs by RCME (grey), and fluorescent selectable markers, 3xP3-EYFP or 3xP3-CFP (m2Turquoise), distinguish dRPi and dRP
respectively. HDR-inhibition region is outlined (pale blue). Pale blue arrows show region where HDR can occur. [C] Design of
dRPpBdonr piggyBac donor transgene for HACK integration of dPR into RpL11-Rpt1, and scheme of knock-in. The donor region (black
bracket) encompasses 2,241bp and 1,550bp hompology arms for RpL11 and Rpt1 respectively (beige) and dRPi and dRP docking
sequences (dRP shown). Outside the donor includes 8 gRNAs as 4 tethered pairs (red) under expression of the PolII promoter (dark
grey arrows). CRISPR targets WT RpL11-Rpt1 shown with Cas9 (pink Pac-man) and gRNAs (red). [D] Act5c-DsRed/3xP3-FP
fluorescence is indicative of the donor transgene. HACK-based integration yields larvae with 3xP3-FP fluorescence alone. [E] PCR
14
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
validation for dRP insertion, and verification of homozygous, heterozygous and wild type adult siblings present in a mixed population
cage. Three, 7-day old homozygous adults adjacent to heterozygous and wild type siblings shown. WT RpL11-Rpt1; primers specific
to unintegrated endogenous locus. dRP; primers specific to dRP inserted within RpL11-Rpt1. dRPupBdonr ; primers specific to
piggyBac donor transgene, spanning Act5C-DsRed. S7; positive control for DNA, primers specific to ribosome S7 sequence. [F]
Individual genomic insertion sites of dRP pBdonr in five families on graphical representation of An. gambiae polytene chromosomes.
The dRP pBdonr
[1], dRP pBdonr
[2] , dRP pBdonr
[3] , dRP pBdonr
[4] , and dRP pBdonr
[5] family names shortened here to [1], [2], [3], [4], and [5],
respectively for brevity. Lines with insertion site sequences corresponding to unknown loci in the annotated genome summarized
under Unknown. Endogenous RpL11-Rpt1 locus on chromosome 3L marked for reference. [G] Unlinked dRP and dRP pBdonr :
Frequency of larvae with 3xP3-CFP fluorescence visibly unlinked from Act5C-DsRed among offspring of males undergoing HACK in
the germline (ie. male genotype {dRPpBdonr /VasCas}). Linked dRP and dRP pBdonr : The frequency of linked HACK events among
those families which demonstrated fluorescently visible HACK (dRP pBdonr
[4] , and dRP pBdonr
[5] ). PCR for dRP HACK-based gene
conversion insertion within larvae which co-inherited dRP pBdonr. visible HACK (dRP pBdonr
[4] , and dRP pBdonr
[5] ). PCR for dRP HACK-based
gene conversion insertion within larvae which co-inherited dRPpBdonr.
Supplementary Figure 1. [A] Canonical population replacement gene drives home in the germline of both sexes and permit
survival of all individuals to facilitate population fixation of the drive allele and any associated cargo. dRP was originally designed to
enable this type of population replacement drive. However this drive is not possible with the lines discussed herein due to
unexpected Ribosome Minute phenotypes [B] Late stages of recessive-lethal replacement (RLR) drive heterozygotes intercross,
resulting in death of half the offspring and heterozygote dominant fixation of drive individuals. Drive occurs in the germline of a single
sex (males here, bright green) contributing (up to) 100% drive-positive chromosomes to the next generation, while heterozygote
survival is permitted by the contribution of a wild type chromosome from the non-driving sex (females here, dark green), which
recapitulates the parental cross ad infinitum (curved green arrow). Concurrent death of homozyogtes (dark grey) each generation
causes simultaneous population suppression by half.
15
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Figure 2. The recessive-lethal dRPi docking site, construction, characterization, validation, and testing drive phenotypes.
[A] The transgene map of the drive-like transgene, gDLT, inserted into the dRPi docking site. [B] PCR validation of dRPi integration
in heterozygotes, shown with wild type, dRP, dRP pBdonr , and water controls. RpL11/Rpt1: Primers specific to wild type RpL11/Rpt1
locus spanning 1569 bp between C-terminal ends of RpL11 and Rpt1 removed during recoding. Primers shown in Figure 1A. dRPi:
primers specific to integration spanning from internal sequence to genomic sequence beyond the homology arm of Rpt1. Predicted
product size of 1922 bp for dRPi (Figure 1). gDLT: Primers amplify from the wild type sequence of RpL11, over the recoding and
ΦC31 recombination sequence, and into the gRNA cassettes on gDLT, 1620 bp predicted size. S7: Control for DNA quality, 500 bp
product expected. Primers not shown. [C] dRPi one-day-old homozygous larvae experience significant poly-ubiquitin aggregation
before death compared to heterozygous and wild type siblings confirming proteasome dysfunction (SDS Nupage gel, 40 larvae per
sample, 11.375 µg protein loaded each genotype, actin loading control shown). Anti-actin also shown. No band in murine positive
control. [D] Western blot targeting Cas9 shows protein production in VZC transgenics but not in gDLT transgenics (E) Rescuing
Cas9 function of gDLT with VZC causes infertility or death in all transheterozygous females compared to transgenic controls
(p<0.0001, One Way ANOVA).
16
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Figure 3. Characterization of the dRP phenotype and observation of ribosome defects. In dRP Rpt1 proteasome function appears
normal, but RpL11 ribosome function is aberrant causing Minute phenotypes. [A] dRP-positive larvae individuals pupate later than
wild type siblings. (Larval competition trays, 50 individuals per genotype, three biological replicates). Percent of total puparium
formed summed each day with day 1 marking observation of first pupa. Mean and SD shown, plotted as inverse survival curve,
Wilcoxon Rank; p<0.001. [B] Significantly fewer dRP homozygotes survive pupation than wild type siblings. Genotypes sorted as
L3/L4 larvae, allowed to pupate, then scored for eclosure or mode of death within 36 h . Surviving adults; successfully eclosed and
flew from surface of pupal dish. Drowned adults; fully formed adults emerged from pupal casing but drown on surface of water. Dead
pupae; pupa dead with no movement, or individuals failed to fully emerge from pupal case before death. (Chi-squared, p<0.0001).
[C] dRP homozygotes are smaller than wild type if they survive pupation (5-day-old female adult siblings, scale bar; 2 mm).
17
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Interestingly, some are sufficiently small that they only develop 4 legs. [D] dRP homozygous female ovaries fail to undergo normal
oogenesis compared to wild type controls which complete vitellogenesis and develop oocytes by 48 h post-blood meal. Ov points to
each of two ovarian lobes, and At denotes the atrium (equivalent to the uterus). dRP homozygotes bloodfed twice to guarantee
vitellogenic surplus, controls received a single blood-feed (75x magnification, scale bar; 500 µm). [E] Homozygote dRP express
significantly less RpL11 mRNA transcript than heterozygous and wild type siblings (ANOVA p = 0.0035). Heterozygotes and wild
type individuals have similar expression levels (one-tailed t-test, p = 0.0585), while homozygotes express significantly less than
heterozygous siblings (one-tailed t-test, p = 0.0293), with highly significant 41% decrease in expression between wild type and
homozygotes (one-tailed t-test, p = 0.0008). [F] Rpt1 mRNA transcript levels in pupae are nonsignificantly different between dRP
sibling genotypes (qRTPCR , four biological replicates per genotype, two pupae per sample, non-significant difference between
groups (p = 0.3878 ANOVA, mean and SD). [G] There are no significant accumulations of poly-ubqiquitin aggregates in dRP
homozygous pupae compared to wt siblings. (Western Blot, two pupae per sample, 40 ug per well)
References
1. Esvelt KM, Smidler AL, Catteruccia F, Church GM. Emerging technology: concerning
RNA-guided gene drives for the alteration of wild populations. Elife. 2014;3: e03401.
2. Burt A, Trivers RL. Genes in conflict: The biology of selfish genetic elements. London,
England: Belknap Press; 2006. doi:10.4159/9780674029118
3. Kyrou K, Hammond AM, Galizi R, Kranjc N, Burt A, Beaghton AK, et al. A CRISPR–Cas9
gene drive targeting doublesex causes complete population suppression in caged
Anopheles gambiae mosquitoes. Nat Biotechnol. 2018;36: 1062–1066.
4. Hammond AM, Kyrou K, Bruttini M, North A, Galizi R, Karlsson X, et al. The creation and
18
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
selection of mutations resistant to a gene drive over multiple generations in the malaria
mosquito. PLoS Genet. 2017;13: e1007039.
5. Hammond A, Karlsson X, Morianou I, Kyrou K, Beaghton A, Gribble M, et al. Regulating the
expression of gene drives is key to increasing their invasive potential and the mitigation of
resistance. PLoS Genet. 2021;17: e1009321.
6. Fuchs S, Garrood WT, Beber A, Hammond A, Galizi R, Gribble M, et al. Resistance to a
CRISPR-based gene drive at an evolutionarily conserved site is revealed by mimicking
genotype fixation. PLoS Genet. 2021;17: e1009740.
7. Carballar-Lejarazú R, Tushar T, Pham TB, James AA. Cas9-mediated maternal effect and
derived resistance alleles in a gene-drive strain of the African malaria vector mosquito,
Anopheles gambiae. Genetics. 2022;221. doi:10.1093/genetics/iyac055
8. Carballar-Lejarazú R, Dong Y, Pham TB, Tushar T, Corder RM, Mondal A, et al. Dual
effector population modification gene-drive strains of the African malaria mosquitoes,
Anopheles gambiae and Anopheles coluzzii. Proc Natl Acad Sci U S A. 2023;120:
e2221118120.
9. Gantz VM, Jasinskiene N, Tatarenkova O, Fazekas A, Macias VM, Bier E, et al. Highly
efficient Cas9-mediated gene drive for population modification of the malaria vector
mosquito Anopheles stephensi. Proc Natl Acad Sci U S A. 2015;112: E6736–43.
10. Pham TB, Phong CH, Bennett JB, Hwang K, Jasinskiene N, Parker K, et al. Experimental
population modification of the malaria vector mosquito, Anopheles stephensi. PLoS Genet.
2019;15: e1008440.
11. Adolfi A, Gantz VM, Jasinskiene N, Lee H-F, Hwang K, Terradas G, et al. Efficient
population modification gene-drive rescue system in the malaria mosquito Anopheles
stephensi. Nat Commun. 2020;11: 5553.
12. Hammond A, Galizi R, Kyrou K, Simoni A, Siniscalchi C, Katsanos D, et al. A
CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito
vector Anopheles gambiae. Nat Biotechnol. 2016;34: 78–83.
13. Nash A, Urdaneta GM, Beaghton AK, Hoermann A, Papathanos PA, Christophides GK, et
al. Integral gene drives for population replacement. Biol Open. 2019;8.
19
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
doi:10.1242/bio.037762
14. Simoni A, Hammond AM, Beaghton AK, Galizi R, Taxiarchi C, Kyrou K, et al. A male-biased
sex-distorter gene drive for the human malaria vector Anopheles gambiae. Nat Biotechnol.
2020;38: 1054–1060.
15. Carballar-Lejarazú R, Ogaugwu C, Tushar T, Kelsey A, Pham TB, Murphy J, et al.
Next-generation gene drive for population modification of the malaria vector mosquito,
Anopheles gambiae. Proc Natl Acad Sci U S A. 2020;117: 22805–22814.
16. Hoermann A, Tapanelli S, Capriotti P, Del Corsano G, Masters EK, Habtewold T, et al.
Converting endogenous genes of the malaria mosquito into simple non-autonomous gene
drives for population replacement. Elife. 2021;10. doi:10.7554/eLife.58791
17. Garrood WT, Kranjc N, Petri K, Kim DY, Guo JA, Hammond AM, et al. Analysis of off-target
effects in CRISPR-based gene drives in the human malaria mosquito. Proc Natl Acad Sci U
S A. 2021;118. doi:10.1073/pnas.2004838117
18. Hammond A, Pollegioni P, Persampieri T, North A, Minuz R, Trusso A, et al. Gene-drive
suppression of mosquito populations in large cages as a bridge between lab and field. Nat
Commun. 2021;12: 4589.
19. Ellis DA, Avraam G, Hoermann A, Wyer CAS, Ong YX, Christophides GK, et al. Testing
non-autonomous antimalarial gene drive effectors using self-eliminating drivers in the
African mosquito vector Anopheles gambiae. PLoS Genet. 2022;18: e1010244.
20. Hoermann A, Habtewold T, Selvaraj P, Del Corsano G, Capriotti P, Inghilterra MG, et al.
Gene drive mosquitoes can aid malaria elimination by retarding Plasmodium sporogonic
development. Sci Adv. 2022;8: eabo1733.
21. Green EI, Jaouen E, Klug D, Proveti Olmo R, Gautier A, Blandin S, et al. A population
modification gene drive targeting both Saglin and Lipophorin impairs Plasmodium
transmission in Anopheles mosquitoes. Elife. 2023;12. doi:10.7554/eLife.93142
22. Champer J, Liu J, Oh SY, Reeves R, Luthra A, Oakes N, et al. Reducing resistance allele
formation in CRISPR gene drive. Proc Natl Acad Sci U S A. 2018;115: 5522–5527.
23. DiCarlo JE, Chavez A, Dietz SL, Esvelt KM, Church GM. Safeguarding CRISPR-Cas9 gene
20
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
drives in yeast. Nat Biotechnol. 2015;33: 1250–1255.
24. Noble C, Olejarz J, Esvelt KM, Church GM, Nowak MA. Evolutionary dynamics of CRISPR
gene drives. Sci Adv. 2017;3: e1601964.
25. Champer J, Yang E, Lee E, Liu J, Clark AG, Messer PW. A CRISPR homing gene drive
targeting a haplolethal gene removes resistance alleles and successfully spreads through a
cage population. Proc Natl Acad Sci U S A. 2020;117: 24377–24383.
26. Gantz VM, Bier E. The mutagenic chain reaction: A method for converting heterozygous to
homozygous mutations. Science. 2015. pp. 442–444. doi:10.1126/science.aaa5945
27. Grunwald HA, Gantz VM, Poplawski G, Xu X-RS, Bier E, Cooper KL. Super-Mendelian
inheritance mediated by CRISPR–Cas9 in the female mouse germline. Nature. 2019;566:
105–109.
28. Oberhofer G, Ivy T, Hay BA. Behavior of homing endonuclease gene drives targeting genes
required for viability or female fertility with multiplexed guide RNAs. Proc Natl Acad Sci U S
A. 2018;115: E9343–E9352.
29. Burt A, Koufopanou V. Homing endonuclease genes: the rise and fall and rise again of a
selfish element. Curr Opin Genet Dev. 2004;14: 609–615.
30. Oberhofer G, Ivy T, Hay BA. Gene drive that results in addiction to a temperature-sensitive
version of an essential gene triggers population collapse in Drosophila. Proc Natl Acad Sci
U S A. 2021;118: e2107413118.
31. Marygold SJ, Roote J, Reuter G, Lambertsson A, Ashburner M, Millburn GH, et al. The
ribosomal protein genes and Minute loci of Drosophila melanogaster. Genome Biol. 2007;8:
R216.
32. Leslie M. There are millions of protein factories in every cell. Surprise, they’re not all the
same. Science. 2017. doi:10.1126/science.aan6994
33. Förster F, Lasker K, Beck F, Nickell S, Sali A, Baumeister W. An atomic model
AAA-ATPase/20S core particle sub-complex of the 26S proteasome. Biochem Biophys Res
Commun. 2009;388: 228–233.
34. Volohonsky G, Terenzi O, Soichot J, Naujoks DA, Nolan T, Windbichler N, et al. Tools for
21
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Anopheles gambiae Transgenesis. G3 . 2015;5: 1151–1163.
35. Werling K, Shaw WR, Itoe MA, Westervelt KA, Marcenac P, Paton DG, et al. Steroid
Hormone Function Controls Non-competitive Plasmodium Development in Anopheles. Cell.
2019;177: 315–325.e14.
36. Lin C-C, Potter CJ. Editing Transgenic DNA Components by Inducible Gene Replacement
in Drosophila melanogaster. Genetics. 2016;203: 1613–1628.
37. Konopka JK, Task D, Poinapen D, Potter CJ. Neurogenetic identification of mosquito
sensory neurons. bioRxiv. 2022. p. 2022.11.22.517370. doi:10.1101/2022.11.22.517370
38. Chen J-M, Cooper DN, Chuzhanova N, Férec C, Patrinos GP. Gene conversion:
mechanisms, evolution and human disease. Nat Rev Genet. 2007;8: 762–775.
39. Meredith JM, Underhill A, McArthur CC, Eggleston P. Next-Generation Site-Directed
Transgenesis in the Malaria Vector Mosquito Anopheles gambiae: Self-Docking Strains
Expressing Germline-Specific phiC31 Integrase. PLoS ONE. 2013. p. e59264.
doi:10.1371/journal.pone.0059264
40. Thibaudeau TA, Smith DM. A Practical Review of Proteasome Pharmacology. Pharmacol
Rev. 2019;71: 170–197.
41. Smidler AL, Terenzi O, Soichot J, Levashina EA, Marois E. Targeted mutagenesis in the
malaria mosquito using TALE nucleases. PLoS One. 2013;8: e74511.
42. Catteruccia F, Benton JP, Crisanti A. An Anopheles transgenic sexing strain for vector
control. Nat Biotechnol. 2005;23: 1414–1417.
43. Zhao J, Fang H, Zhang D. Expanding application of CRISPR-Cas9 system in
microorganisms. Synth Syst Biotechnol. 2020;5: 269–276.
44. Smidler AL, Marrogi E, Kauffman J, Paton DG, Westervelt KA, Church GM, et al.
CRISPR-mediated germline mutagenesis for genetic sterilization of Anopheles gambiae
males. Sci Rep. 2024;14: 4057.
45. Cramton SE, Laski FA. string of pearls encodes Drosophila ribosomal protein S2, has
Minute-like characteristics, and is required during oogenesis. Genetics. 1994;137:
1039–1048.
22
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
46. Estep AS, Sanscrainte ND, Becnel JJ. DsRNA-mediated targeting of ribosomal transcripts
RPS6 and RPL26 induces long-lasting and significant reductions in fecundity of the vector
Aedes aegypti. J Insect Physiol. 2016;90: 17–26.
47. Lambertsson A. The minute genes in Drosophila and their molecular functions. Adv Genet.
1998;38: 69–134.
48. Lin JI, Mitchell NC, Kalcina M, Tchoubrieva E, Stewart MJ, Marygold SJ, et al. Drosophila
ribosomal protein mutants control tissue growth non-autonomously via effects on the
prothoracic gland and ecdysone. PLoS Genet. 2011;7: e1002408.
49. Sulima SO, Hofman IJF, De Keersmaecker K, Dinman JD. How Ribosomes Translate
Cancer. Cancer Discovery. 2017. pp. 1069–1087. doi:10.1158/2159-8290.cd-17-0550
50. Banerjee D, Sanyal S. Protein Folding Activity of the Ribosome (PFAR) –– A Target for
Antiprion Compounds. Viruses. 2014. pp. 3907–3924. doi:10.3390/v6103907
51. Oberhofer G, Ivy T, Hay BA. Cleave and Rescue, a novel selfish genetic element and
general strategy for gene drive. Proc Natl Acad Sci U S A. 2019;116: 6250–6259.
52. Kandul NP, Liu J, Bennett JB, Marshall JM, Akbari OS. A confinable home-and-rescue gene
drive for population modification. Elife. 2021;10. doi:10.7554/eLife.65939
53. Handler AM, McCombs SD, Fraser MJ, Saul SH. The lepidopteran transposon vector,
piggyBac, mediates germ-line transformation in the Mediterranean fruit fly. Proc Natl Acad
Sci U S A. 1998;95: 7520–7525.
54. Smidler AL, Scott SN, Mameli E, Shaw WR, Catteruccia F. A transgenic tool to assess
Anopheles mating competitiveness in the field. Parasit Vectors. 2018;11: 651.
55. Koerver L, Melzer J, Roca EA, Teichert D, Glatter T, Arama E, et al. The de-ubiquitylating
enzyme DUBA is essential for spermatogenesis in Drosophila. Cell Death Differ. 2016;23:
2019–2030.
56. Rogers DW, Whitten MMA, Thailayil J, Soichot J, Levashina EA, Catteruccia F. Molecular
and cellular components of the mating machinery in Anopheles gambiae females. Proc Natl
Acad Sci U S A. 2008;105: 19390–19395.
23
.CC-BY-NC 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted March 3, 2025. ; https://doi.org/10.1101/2025.03.03.641265doi: bioRxiv preprint
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.